Technical Analysis for MDNAF - Medicenna Therapeutics Corp.

Grade Last Price % Change Price Change
grade D 0.898 -2.39% -0.0220
MDNAF closed down 2.39 percent on Friday, August 23, 2019, on 30 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical MDNAF trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction -2.39%
Wide Bands Range Expansion -2.39%
Narrow Range Bar Range Contraction -1.32%
Wide Bands Range Expansion -1.32%
Spinning Top Other -0.12%

Older signals for MDNAF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that is in the Phase 2b clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA57 for solid tumors and on-malignant cells of the tumor micro-environment; MDNA109, an IL-2 agonist to treat cancer immunotherapies; MDNA209, an IL-2 antagonist for autoimmune diseases; MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis; and MDNA132, an IL-13 agonist to treat solid tumors and IL 13Ralpha2 chimeric antigen receptor T cell. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.
Medicine RTT Medical Specialties Cancer Clinical Medicine Treatment Of Cancer Immunology Immunotherapy Autoimmune Diseases Solid Tumors Tumor Cancer Treatments Asthma Atopic Dermatitis Immunotherapies Fibrosis Virotherapy Brain Tumor Chimeric Antigen Receptor T Cell
Is MDNAF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 2.2396
52 Week Low 0.5056
Average Volume 35,126
200-Day Moving Average 0.0
50-Day Moving Average 1.0969
20-Day Moving Average 0.9472
10-Day Moving Average 0.9415
Average True Range 0.0868
ADX 11.8
+DI 21.5949
-DI 22.064
Chandelier Exit (Long, 3 ATRs ) 0.9296
Chandelier Exit (Short, 3 ATRs ) 1.0472000000000001
Upper Bollinger Band 1.1141
Lower Bollinger Band 0.7803
Percent B (%b) 0.35
BandWidth 35.24071
MACD Line -0.0382
MACD Signal Line -0.0344
MACD Histogram -0.0039
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.9357
Resistance 3 (R3) 0.9395 0.9308 0.9294
Resistance 2 (R2) 0.9308 0.9212 0.9289 0.9273
Resistance 1 (R1) 0.9144 0.9153 0.9101 0.9106 0.9252
Pivot Point 0.9057 0.9057 0.9035 0.9038 0.9057
Support 1 (S1) 0.8893 0.8961 0.8850 0.8855 0.8708
Support 2 (S2) 0.8806 0.8902 0.8787 0.8687
Support 3 (S3) 0.8642 0.8806 0.8666
Support 4 (S4) 0.8604